Nexalin Technology (NXL) Invested Capital (2021)
Nexalin Technology (NXL) posted quarterly Invested Capital of $37200.0 for Q4 2021.
Nexalin Technology (NXL) Invested Capital (2021) Analysis & Trends
Nexalin Technology's Invested Capital history runs 1 years deep, the most recent figure standing at $37200.0 for Q4 2021.
- In Q4 2021, Invested Capital changed N/A year-over-year to $37200.0; the TTM figure through Sep 2022 stood at $37200.0 (changed N/A YoY), while the FY2021 annual figure was $37200.0, changed N/A from the prior year.
- Invested Capital for Q4 2021 stood at $37200.0.
- The five-year high for Invested Capital was $37200.0 in Q4 2021, with the low at $37200.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 3.01 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 750.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.71 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 243.40 Mn |
| 10 | Nexalin Technology | 7.00 Mn | 6.00 Mn | 8,897.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 37,200.00 |